Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.42 |
| ▸ | NPC1 | O15118 | 7/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.42 |
| ▸ | RELA | Q04206 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | TDP2 | O95551 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24466764 | 0.95 | RAB9A (0.41) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24466762 | 0.94 | RAB9A (0.41) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24466698 | 0.94 | RAB9A (0.41) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24476788 | 0.89 | RAB9A (0.43) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24476787 | 0.89 | RAB9A (0.43) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24466711 | 0.89 | RAB9A (0.46) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24476882 | 0.88 | RAB9A (0.45) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24476881 | 0.88 | RAB9A (0.45) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24476883 | 0.88 | RAB9A (0.45) | RAB9AKDM4ENPC1SMN1; SMN2MAPT | |
| SCHEMBL24647349 | 0.87 | RAB9A (0.52) | RAB9AKDM4ENPC1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220173333-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) | 2022-06-02 | — | — | US | disclosed |
| EP-4006025-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220173333-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | KCNH1, OCIAD2, ETFB | RAB9A 1714/4885KDM4E 2755/4885NPC1 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.